Grantham, Mayo, Van Otterloo & Co (GMO)’s CBRE Group CBRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.01M Buy
37,162
+11,004
+42% +$1.52M 0.01% 328
2026
Q1
$3.54M Sell
26,158
-2,772
-10% -$421K 0.01% 369
2025
Q4
$4.65M Sell
28,930
-99,665
-78% -$15.7M 0.01% 320
2025
Q3
$20.3M Sell
128,595
-42,013
-25% -$6.5M 0.06% 167
2025
Q2
$23.9M Sell
170,608
-35,416
-17% -$4.48M 0.07% 154
2025
Q1
$26.9M Sell
206,024
-29,332
-12% -$3.99M 0.08% 153
2024
Q4
$30.9M Sell
235,356
-33,202
-12% -$4.35M 0.1% 135
2024
Q3
$33.4M Buy
268,558
+21,555
+9% +$2.35M 0.1% 139
2024
Q2
$22M Buy
247,003
+174,536
+241% +$15.5M 0.07% 175
2024
Q1
$7.05M Sell
72,467
-61,028
-46% -$5.48M 0.03% 284
2023
Q4
$12.4M Sell
133,495
-226,390
-63% -$17.6M 0.05% 223
2023
Q3
$26.6M Sell
359,885
-27,753
-7% -$2.3M 0.13% 147
2023
Q2
$31.3M Sell
387,638
-12,828
-3% -$960K 0.14% 126
2023
Q1
$29.2M Sell
400,466
-109,300
-21% -$8.93M 0.15% 145
2022
Q4
$39.2M Sell
509,766
-1,162
-0.2% -$85.8K 0.21% 98
2022
Q3
$34.5M Sell
510,928
-144,700
-22% -$11.5M 0.2% 98
2022
Q2
$48.3M Buy
655,628
+70,800
+12% +$5.7M 0.26% 72
2022
Q1
$53.5M Buy
584,828
+86,634
+17% +$8.44M 0.26% 66
2021
Q4
$54.1M Buy
498,194
+20,708
+4% +$2.12M 0.26% 62
2021
Q3
$46.5M Buy
477,486
+43,290
+10% +$4.02M 0.23% 75
2021
Q2
$37.2M Buy
434,196
+88,711
+26% +$7.57M 0.19% 91
2021
Q1
$27.3M Buy
345,485
+39,785
+13% +$2.81M 0.15% 99
2020
Q4
$19.2M Buy
+305,700
New +$17.3M 0.12% 117
2020
Q3
Sell
-20,421
Closed -$923K 770
2020
Q2
$923K Sell
20,421
-15,328
-43% -$661K 0.01% 545
2020
Q1
$1.35M Buy
35,749
+600
+2% +$33.2K 0.01% 459
2019
Q4
$2.15M Sell
35,149
-7,300
-17% -$404K 0.01% 387
2019
Q3
$2.25M Sell
42,449
-24,500
-37% -$1.29M 0.02% 403
2019
Q2
$3.43M Sell
66,949
-8,900
-12% -$442K 0.02% 362
2019
Q1
$3.75M Sell
75,849
-81,600
-52% -$3.83M 0.03% 315
2018
Q4
$6.3M Sell
157,449
-34,900
-18% -$1.44M 0.05% 169
2018
Q3
$8.48M Sell
192,349
-73,600
-28% -$3.51M 0.06% 163
2018
Q2
$12.7M Sell
265,949
-22,051
-8% -$1.04M 0.09% 138
2018
Q1
$13.6M Sell
288,000
-25,100
-8% -$1.14M 0.08% 134
2017
Q4
$13.6M Buy
313,100
+117,800
+60% +$4.88M 0.08% 141
2017
Q3
$7.4M Buy
195,300
+155,700
+393% +$5.73M 0.04% 194
2017
Q2
$1.44M Buy
+39,600
New +$1.38M 0.01% 346
2015
Q4
Sell
-21,400
Closed -$685K 560
2015
Q3
$685K Sell
21,400
-41,900
-66% -$1.49M ﹤0.01% 440
2015
Q2
$2.34M Sell
63,300
-13,400
-17% -$509K 0.01% 316
2015
Q1
$2.97M Buy
76,700
+4,700
+7% +$162K 0.01% 310
2014
Q4
$2.47M Sell
72,000
-10,217
-12% -$327K 0.01% 316
2014
Q3
$2.44M Sell
82,217
-2,489
-3% -$78.2K 0.01% 332
2014
Q2
$2.71M Sell
84,706
-24,783
-23% -$716K 0.01% 343
2014
Q1
$3M Sell
109,489
-17,300
-14% -$466K 0.01% 361
2013
Q4
$3.33M Sell
126,789
-23,111
-15% -$550K 0.01% 364
2013
Q3
$3.47M Buy
149,900
+71,700
+92% +$1.66M 0.01% 357
2013
Q2
$1.83M Buy
+78,200
New +$1.86M ﹤0.01% 403

Other funds holding CBRE

Grantham, Mayo, Van Otterloo & Co (GMO)'s CBRE Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its CBRE Group (CBRE) stake by 42% in Q2 2026, buying an estimated $1.52M and bringing the position to 37,162 shares worth $5.01M. The position accounts for 0.01% of the portfolio, ranked #328.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CBRE in Q2 2013 and has held it in 46 quarters since. The position peaked at $54.1M in Q4 2021. 1,072 funds tracked by Wall St. Rank hold CBRE as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 37,162 shares of CBRE Group worth $5.01M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 11,004 CBRE Group shares in Q2 2026, an estimated $1.52M.
  • CBRE Group made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #328 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CBRE Group in Q2 2013 and has held it in 46 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s CBRE Group position peaked at $54.1M in Q4 2021.
  • 1,072 funds tracked by Wall St. Rank held CBRE Group as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.